Can Medical Marijuana or CBD Interact With Medications or Affect Driving?

The plain-English answer

Yes, an interaction is possible, but that does not mean every combination will cause a problem. Risk can change with THC and CBD amount, route, frequency, age, liver function, and the other medicine. Using several products that cause drowsiness can add another risk.

Do not stop a prescription medicine or change its dose from an online interaction list. Give a physician or pharmacist the exact product label and a complete medication list. They can judge the combination and explain what symptoms or monitoring matter.

Two different ways products can interact

One interaction is added effects. Cannabis, alcohol, sleep medicines, some anxiety medicines, opioids, sedating antihistamines, and other products can each reduce alertness or coordination. Combining them may make drowsiness, dizziness, falls, or driving impairment more likely.

Another interaction changes how the body processes a medicine. CBD and THC can affect liver enzymes in laboratory studies. A laboratory signal does not always become an important interaction in a person. Human evidence is growing, and the size of an effect depends on the dose, formulation, route, and medicine.

What controlled human studies found

A small 2023 crossover study in 18 healthy adults used a very high oral CBD dose with THC and a set of probe medicines. The CBD-plus-THC condition slowed several liver-enzyme pathways and increased exposure to some probes. The THC-only condition did not show the same pattern. This demonstrates a mechanism, not a prediction for every dispensary product or prescription.

A 2026 FDA-led study used two groups of 20 healthy adults. Repeated oral CBD increased citalopram exposure. Measured effects on morphine exposure were smaller. The study used set doses under research conditions and did not establish what every patient should do. A pharmacist or prescriber still needs the exact medicine and product details.

Why prescription CBD evidence needs careful wording

The FDA-approved CBD medicine Epidiolex has a controlled formula and prescribing label. Its label describes liver monitoring, drowsiness, and interactions involving medicines such as clobazam and valproate. This is important safety evidence. It does not prove that a retail or dispensary CBD product has the same dose, purity, use, or benefit.

FDA also warns that nonprescription CBD can affect other medicines. It can add to sedation with alcohol or drugs that slow brain activity. A product being sold as hemp or non-intoxicating does not make the interaction question disappear.

Medication groups worth flagging in the conversation

Tell the clinician about medicines that cause sleepiness or dizziness. Also flag medicines where a change in blood level could matter. Examples may include blood thinners, antiseizure medicines, transplant medicines, heart medicines, antidepressants, opioids, sleep medicines, and sedating allergy products. This is a review prompt, not a complete list or a claim that every item will interact.

Also mention alcohol, nicotine, supplements, and over-the-counter products. The useful question is not simply whether cannabis interacts with a category. Ask whether this exact product, amount, route, and schedule creates a meaningful risk with this exact regimen.

Driving: there is no universal countdown

CDC says cannabis can slow reaction time and decision-making, impair coordination, and distort perception. It is difficult to connect a person's THC level to that person's driving impairment. A blood result, product label, tolerance, or feeling normal is not a reliable permission slip to drive.

Do not copy a single wait time from one study. Inhaled and swallowed products have different timing, people vary, and combining cannabis with alcohol or medicines can increase impairment. Florida law prohibits driving when alcohol or a controlled substance impairs normal faculties. Plan a sober driver or another ride instead of trying to calculate the legal edge.

What a new national young-adult survey can and cannot show

A 2026 analysis pooled 2021-2024 national survey responses from 17,141 drivers ages 18 to 25 who reported using cannabis in the past year. An estimated 28.0% self-reported driving under the influence of cannabis during that year. Reported driving under the influence was more common across higher cannabis-use-frequency groups and was also associated with cannabis use disorder and using alcohol and cannabis at the same time.

This was a cross-sectional, self-reported national survey. It did not measure a person's impairment during a drive, establish that cannabis caused a crash, produce a Florida-specific rate, or identify a safe wait time. A medical card, frequent use, tolerance, or feeling normal is not personal driving clearance.

A five-minute medication review

Write down each medicine and supplement, its strength, when you take it, and why you take it. For cannabis or CBD, record the route, THC and CBD per serving, amount used, and time used. Note whether it is a Florida MMTC product, a prescription, or a retail hemp product.

Ask the physician or pharmacist: Could these effects add together? Could the cannabinoid change a medicine level? Does liver or kidney function matter? Should any symptom or laboratory value be monitored? What should I do if I become unusually sleepy, confused, dizzy, unsteady, or otherwise unwell?